Saturday, April 20, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

‘COVID-19 Rebound’ May Be Worse Than Initial COVID Illness

Paxlovid pills

On May 24, 2022, the U.S. Centers for Disease Control and Prevention (CDC) issued a health advisory to health care providers, public health departments and the general public regarding Pfizer’s antiviral drug Paxlovid, designed to treat symptoms of COVID-19. The advisory warns that some people who take Paxlovid may experience a recurrence of COVID symptoms […]

Claims for Injury, Death from COVID Shots Surge

numbness in the wrist

Opinion | The Countermeasures Injury Compensation Program (CICP) is a program of the U.S. government that provide financial compensation for people who have suffered serious injuries or death from vaccines, biologics, antivirals or other drugs, as well medical devices used to “diagnose, prevent or treat a declared pandemic, epidemic or security threat.” The program was […]

More Vaccinated, Boosted U.S. Government Leaders Test Positive for Coronavirus

Anthony Fauci

Since The Vaccine Reaction began publishing articles last year (Vaccinated Americans Count Their Blessings Despite Getting COVID and The Vaxxed and Boosted Get COVID But Praise Vaccines for “Mild” Symptoms) tracking members of the U.S. Congress who tested positive for SARS-CoV-2, despite being fully vaccinated and boosted, dozens of additional U.S. Senators and Representatives have tested […]

FDA Panel Recommends EUA for Novavax COVID-19 Vaccine

Novavax's COVID-19 vaccine

Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]

Guillain-Barré Syndrome Linked to COVID-19 Shots

Guillain-Barre Syndrome

A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]

Search in Site

To search in site, type your keyword and hit enter

Search